This information was published on 2025-09-03T13:29:03 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2538344 (IR 1849066) |
| (220) |
31 Jan 2025
|
| (300) |
US, 31 Jul 2024, 98675742
|
| (500) |
The mark consists of the stacked terms "ENSHO THERAPEUTICS" with a design of a flame to the left of the terms.
|
| (511) (510) |
Class 5
Pharmaceuticals for the treatment and prevention of inflammatory bowel diseases and gastrointestinal diseases and disorders, including, ulcerative colitis and Crohn's disease. |
| (540) |
|
| (550) | Figurative |
| (730) |
Ensho Therapeutics, Inc.
|
| (750) |
Simpson Grierson
|
Find out more about publications on the About page.